By Saskya Vandoorne, Gianluca Mezzofiore, Simone McCarthy and Yong Xiong, CNN (CNN) — The first of two vessels carrying 1,000 tons of a Chinese-made ...

Biological motors, which aid microorganism movement in fluids, are composed of two components—the rotor and stators. Despite ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

FDA approves suzetrigine, a non-opioid painkiller that blocks sodium channels, offering potent relief without addiction risks.

In 2004, a research group at Peking University First Hospital discovered a mutation in the gene coding for a sodium-channel ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

It works by selectively blocking sodium channels on pain-sensing nerve cells, providing opioid-level pain suppression without the risks of addiction, sedation or overdose. On Thursday, the US Food ...

The FT said the Iranian-flagged ships, the Golbon and the Jairan, are expected to carry more than 1,000 tonnes of sodium perchlorate, which is used to make ammonium perchlorate, the main ...

This year will be Prince William's 20th as patron for Centrepoint, a charity dedicated to helping homeless youth Janine Henni is a Royals Staff Writer for PEOPLE Digital, covering modern ...